» Articles » PMID: 23816032

Adverse Outcomes Among Women Presenting with Signs and Symptoms of Ischemia and No Obstructive Coronary Artery Disease: Findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Angiographic...

Overview
Journal Am Heart J
Date 2013 Jul 3
PMID 23816032
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Women presenting with signs and symptoms of myocardial ischemia frequently have no or nonobstructive coronary artery disease (CAD).

Objective: This study aimed to investigate the associations between angiographic measures and longer-term clinical outcomes among women with signs and symptoms of ischemia referred for coronary angiography.

Methods: A prospective cohort analysis of women referred for coronary angiography and enrolled in the National Heart, Lung, and Blood Institute-sponsored WISE was performed. An angiographic severity score was prospectively developed, assigning points for any stenosis weighted by stenosis severity, location, and collaterals and was then tested for prediction for adverse outcome in 917 women, over a median of 9.3 years.

Setting: The study was conducted in referral centers.

Patients: Women with signs and/or symptoms of myocardial ischemia referred for coronary angiography were consecutively consented and enrolled in a prospective study.

Main Outcome Measures: Main outcomes included first occurrence of cardiovascular death or nonfatal myocardial infarction. Hospitalization for angina was a secondary outcome.

Results: Cardiovascular death or myocardial infarction at 10 years occurred in 6.7%, 12.8%, and 25.9% of women with no, nonobstructive, and obstructive CAD (P < .0001), respectively. Cumulative 10-year cardiovascular death or myocardial infarction rates showed progressive, near-linear increases for each WISE CAD severity score range of 5, 5.1 to 10, 10.1 to 20, 20.1 to 50, and >50. The optimal threshold in the WISE severity score classifications for predicting cardiovascular mortality was >10 (eg, 5.0-10 vs 10.1-89), with both a sensitivity and specificity of 0.64 and an area under the curve of 0.64 (P = .02, 95% CI 0.59-0.68).

Conclusions: Among women with signs and symptoms of ischemia, nonobstructive CAD is common and associated with adverse outcomes over the longer term. The new WISE angiographic score appears to be useful for risk prediction in this population.

Citing Articles

Understanding Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): a comprehensive meta-analysis of clinical characteristics, management, and prognosis compared to MI with the Obstructive Coronary Artery (MIOCA).

Khorasani N, Mohammadi Y, Sarpoli M, Kazemi T, Riahi S BMC Cardiovasc Disord. 2025; 25(1):143.

PMID: 40025434 PMC: 11871625. DOI: 10.1186/s12872-025-04504-2.


ANOCA, INOCA, MINOCA: The New Frontier of Coronary Syndromes.

Parlati A, Nardi E, Sucato V, Madaudo C, Leo G, Rajah T J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997498 PMC: 11856364. DOI: 10.3390/jcdd12020064.


QUIET WARRIOR - Rationale and design: An ancillary study to the Women's IschemiA TRial to Reduce Events in Nonobstructive CAD (WARRIOR).

Dasa O, Handberg E, Dey D, Sarder P, Lo M, Tamarappoo B Am Heart J Plus. 2025; 51:100508.

PMID: 39995515 PMC: 11847744. DOI: 10.1016/j.ahjo.2025.100508.


TIMI Frame Count and Coronary Function in Women With Suspected Ischemia and Nonobstructed Coronary Arteries.

Paquin A, Muhyieddeen A, Wei J, Wiens G, Cui Y, Pepine C JACC Adv. 2025; 4(3):101611.

PMID: 39983610 PMC: 11889343. DOI: 10.1016/j.jacadv.2025.101611.


Unveiling the Longitudinal Journey: 3-Year Follow-up of Women with MINOCA and INOCA in a Specialized Heart Centre.

Theberge E, Burden E, Leung K, Parvand M, Prodan-Bhalla N, Humphries K CJC Open. 2024; 6(12):1462-1475.

PMID: 39735950 PMC: 11681349. DOI: 10.1016/j.cjco.2024.08.013.


References
1.
Arbustini E, Dal Bello B, Morbini P, Burke A, Bocciarelli M, Specchia G . Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999; 82(3):269-72. PMC: 1729173. DOI: 10.1136/hrt.82.3.269. View

2.
Gulati M, Cooper-DeHoff R, McClure C, Johnson B, Shaw L, Handberg E . Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009; 169(9):843-50. PMC: 2782882. DOI: 10.1001/archinternmed.2009.50. View

3.
Olson M, Kelsey S, Matthews K, Shaw L, Sharaf B, Pohost G . Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. Eur Heart J. 2003; 24(16):1506-14. DOI: 10.1016/s0195-668x(03)00279-3. View

4.
Merz C, Kelsey S, Pepine C, Reichek N, Reis S, Rogers W . The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol. 1999; 33(6):1453-61. DOI: 10.1016/s0735-1097(99)00082-0. View

5.
Goldstein J, Demetriou D, Grines C, Pica M, Shoukfeh M, ONeill W . Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000; 343(13):915-22. DOI: 10.1056/NEJM200009283431303. View